• Study of Capivasertib and Abiraterone for Patients with Metastatic Hormone-Sensitive Prostate Cancer with PTEN Deficiency

    Not recruiting

    3 1 1
    Investigated diseases:
    Belgium Bulgaria Czechia France Germany The Netherlands +3

  • Study on Bintrafusp Alfa with Chemoradiation for Patients with Esophageal Squamous Cell Carcinoma

    Not recruiting

    2 1 1
    Investigated diseases:
    The Netherlands

  • Study of Felzartamab for Patients with Membranous Nephropathy Resistant to Anti-CD20 Therapy

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Italy

  • Study on the Effectiveness of HPV 9-Valent Vaccine in Women Undergoing LEEP for High-Grade Cervical Lesions or Early Cervical Cancer

    Not recruiting

    3 1 1
    Investigated diseases:
    Italy

  • Study on the Effectiveness and Safety of BGY-1601-VT for Women with Acute Vaginal Infections, Including Bacterial Vaginosis and Yeast Infections

    Not recruiting

    2 1
    Investigated diseases:
    France Germany

  • Study on the Long-Term Safety of ND0612 (Carbidopa, Levodopa) Infusion for Patients with Advanced Parkinson’s Disease

    Not recruiting

    2 1 1
    Investigated diseases:
    Austria France Italy Poland

  • Study to Predict Tofacitinib Effectiveness in Psoriatic Arthritis Patients Using Tofacitinib, Methotrexate, and Folic Acid

    Not recruiting

    3 1 1 1
    Investigated diseases:
    The Netherlands

  • Study on Tezepelumab for Symptom Relief in Patients Aged 12-80 with Eosinophilic Esophagitis

    Not recruiting

    3 1 1
    Austria Belgium Czechia Denmark Finland Germany +7

  • Study of nirmatrelvir and ritonavir (Paxlovid) for prevention of long COVID-19 in patients with acute COVID-19 infection in Norway

    Not recruiting

    3 1 1
    Investigated diseases:
    Norway

  • Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

    Not recruiting

    2 1
    Investigated diseases:
    Austria France Germany Greece Italy Poland +3

powered by